JP2003516525A5 - - Google Patents

Download PDF

Info

Publication number
JP2003516525A5
JP2003516525A5 JP2001542908A JP2001542908A JP2003516525A5 JP 2003516525 A5 JP2003516525 A5 JP 2003516525A5 JP 2001542908 A JP2001542908 A JP 2001542908A JP 2001542908 A JP2001542908 A JP 2001542908A JP 2003516525 A5 JP2003516525 A5 JP 2003516525A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001542908A
Other languages
Japanese (ja)
Other versions
JP2003516525A (ja
JP4612261B2 (ja
Filing date
Publication date
Priority claimed from US09/459,137 external-priority patent/US6248353B1/en
Application filed filed Critical
Publication of JP2003516525A publication Critical patent/JP2003516525A/ja
Publication of JP2003516525A5 publication Critical patent/JP2003516525A5/ja
Application granted granted Critical
Publication of JP4612261B2 publication Critical patent/JP4612261B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001542908A 1999-12-10 2000-11-20 予め作製されたリポソームへの精製膜蛋白質の再構成 Expired - Fee Related JP4612261B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/459,137 US6248353B1 (en) 1999-12-10 1999-12-10 Reconstitution of purified membrane proteins into preformed liposomes
US09/459,137 1999-12-10
PCT/US2000/031927 WO2001041740A2 (en) 1999-12-10 2000-11-20 Reconstitution of purified membrane proteins into preformed liposomes

Publications (3)

Publication Number Publication Date
JP2003516525A JP2003516525A (ja) 2003-05-13
JP2003516525A5 true JP2003516525A5 (https=) 2007-11-22
JP4612261B2 JP4612261B2 (ja) 2011-01-12

Family

ID=23823557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001542908A Expired - Fee Related JP4612261B2 (ja) 1999-12-10 2000-11-20 予め作製されたリポソームへの精製膜蛋白質の再構成

Country Status (7)

Country Link
US (2) US6248353B1 (https=)
EP (1) EP1239833B1 (https=)
JP (1) JP4612261B2 (https=)
AT (1) ATE272393T1 (https=)
DE (1) DE60012785T2 (https=)
ES (1) ES2225271T3 (https=)
WO (1) WO2001041740A2 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
PT1031346E (pt) 1999-01-27 2002-09-30 Idea Ag Vacinacao nao invasiva atraves da pele
SI1031347T1 (en) 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
DK1345959T3 (da) * 2000-11-20 2011-09-05 Univ Illinois Membranscaffoldproteiner
US7622437B2 (en) * 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
US7592008B2 (en) * 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
US7083958B2 (en) * 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US6596543B2 (en) * 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
US7015193B2 (en) * 2001-04-20 2006-03-21 University Of Vermont Compositions and methods to control bleeding
JP2005530704A (ja) * 2002-03-05 2005-10-13 トランセイブ, インク. 細胞内感染を予防及び治療するための吸入システム
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US20050032113A1 (en) * 2003-07-17 2005-02-10 Mitsubishi Pharma Corporation Membrane protein library for proteome analysis and method for preparing same
CN101057145B (zh) * 2004-06-23 2014-10-22 得克萨斯系统大学评议会 使用双粒子复合体检测生物分子的方法和组合物
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
EP1869082B1 (en) * 2005-03-04 2011-04-13 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
JP2007106679A (ja) * 2005-10-11 2007-04-26 Shino Test Corp 血液凝固反応促進剤
EP1939218A1 (en) * 2006-12-29 2008-07-02 Thrombotargets Europe, S.L. Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
EP2118129A4 (en) * 2007-03-01 2010-04-28 Life Technologies Corp ISOLATED PHOSPHOLIPID PROTEIN PARTICLES
WO2008109712A2 (en) * 2007-03-05 2008-09-12 Washington University Nanoparticle delivery systems for membrane-integrating peptides
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
EP2062661A1 (en) * 2007-09-28 2009-05-27 Proviron Holding Organic de-icer removal
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
WO2009105624A2 (en) * 2008-02-21 2009-08-27 Massachusetts Institute Of Technology Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity
WO2009146523A1 (en) 2008-06-05 2009-12-10 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
US8956600B2 (en) 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US10525152B2 (en) 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
KR101458315B1 (ko) 2013-07-19 2014-11-04 전북대학교산학협력단 표면 개질된 리포좀 및 그 제조방법
JP6626761B2 (ja) * 2016-03-30 2019-12-25 シスメックス株式会社 プロトロンビン時間測定用試薬およびその製造方法
JP6652873B2 (ja) * 2016-03-30 2020-02-26 シスメックス株式会社 プロトロンビン時間測定用試薬、その製造方法およびプロトロンビン時間の測定方法
WO2019200240A1 (en) 2018-04-13 2019-10-17 Board Of Regents, The University Of Texas System Transmembrane stem cell factor (tm-scf) lipid nanocarriers and methods of use thereof
US20210270854A1 (en) * 2018-07-06 2021-09-02 Lsi Medience Corporation Liposome-containing liquid reagent for measuring blood coagulation ability
JP7153519B2 (ja) * 2018-09-28 2022-10-14 シスメックス株式会社 凝固時間測定用試薬及びその製造方法、試薬キット及び凝固時間の測定方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238873A (https=) 1958-05-16
JPS56129859A (en) * 1980-03-14 1981-10-12 Sekisui Chem Co Ltd Plastic container for blood inspection
US4873089A (en) * 1985-07-12 1989-10-10 Cornell Research Foundation Inc., Cornell University Proteoliposomes as drug carriers
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
JPH0650999B2 (ja) 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法
US5472850A (en) 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
DK0464533T3 (da) 1990-06-28 1999-04-26 Gen Hospital Corp Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
US5314695A (en) 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5248590A (en) 1991-07-22 1993-09-28 Becton, Dickinson And Company Surface modified liposomes
ES2115679T3 (es) * 1991-10-04 1998-07-01 Dade Behring Inc Preparacion de reactivos de tiempo de protrombina a partir de factor de tejido humano recombinante y de fosfolipidos sinteticos y naturales purificados.
AU674139B2 (en) 1992-04-13 1996-12-12 Ortho Diagnostic Systems Inc. Synthetic phospholipid reagent
US5358853A (en) 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
DE4243729A1 (de) 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Reaktivierung von gereinigten Membranproteinen
EP0748215B1 (en) 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
DE4416166C2 (de) 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE69832628T2 (de) * 1997-04-23 2006-09-07 Instrumentation Laboratory S.P.A. Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
JP4039722B2 (ja) * 1997-12-01 2008-01-30 シスメックス株式会社 複合因子測定試薬
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes

Similar Documents

Publication Publication Date Title
JP2002543532A5 (https=)
BE2010C009I2 (https=)
JP2003517162A5 (https=)
JP2003510708A5 (https=)
JP2003503991A5 (https=)
JP2003512104A5 (https=)
JP2003516525A5 (https=)
JP2003507113A5 (https=)
JP2001201355A5 (https=)
JP2001285820A5 (https=)
JP2001346178A5 (https=)
JP2003505950A5 (https=)
JP2001324365A5 (https=)
JP2001254768A5 (https=)
JP2002098738A5 (https=)
JP2002062257A5 (https=)
JP2002114281A5 (https=)
HU0004069D0 (https=)
IN192833B (https=)
CN3135387S (https=)
CN3146291S (https=)
CN3138718S (https=)
CN3141399S (https=)
CN3144928S (https=)
CN3144782S (https=)